Press Releases from DelveInsight Business Research LLP (4878 total)
Graves Ophthalmopathy Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Graves Ophthalmopathy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Graves Ophthalmopathy pipeline landscape. It covers the…
Graft Versus Host Disease Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Graft versus host disease Pipeline Insight 2024" report provides comprehensive insights about 60+ GvHD companies and 65+ pipeline drugs in Graft versus host disease…
Glioma Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Glioma Pipeline Insight 2024" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in the Glioma pipeline landscape. It covers the Glioma…
Dry Age-related Macular Degeneration Pipeline Therapeutics Assessment Report 202 …
DelveInsight's, "Dry Age-related Macular Degeneration Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 80+ pipeline drugs in Dry Age-related Macular Degeneration…
Diabetic Peripheral Neuropathy Pipeline Therapeutics Assessment Report 2024 (Upd …
DelveInsight's, "Diabetic Peripheral Neuropathy Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Diabetic Peripheral Neuropathy pipeline landscape. It…
Angelman Syndrome Treatment Market Size is expected to grow by 2034, estimates D …
Angelman Syndrome Treatment Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of…
Peripheral Arterial Disease Pipeline Therapeutics Assessment Report 2024 (Update …
DelveInsight's, "Peripheral Arterial Disease Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Peripheral Arterial Disease pipeline landscape. It…
Epilepsy Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Epilepsy Pipeline Insight 2024" report provides comprehensive insights about 85+ companies and 90+ pipeline drugs in Epilepsy pipeline landscape. It covers the pipeline drug…
Diffuse Large B-cell Lymphoma Pipeline Therapeutics Assessment Report 2024 (Upda …
DelveInsight's, "Diffuse Large B-Cell Lymphoma Pipeline Insight 2024" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Diffuse Large B-Cell Lymphoma pipeline…
Chronic Obstructive Pulmonary Disease Pipeline Therapeutics Assessment Report 20 …
(Albany, United States) As per DelveInsight's assessment, globally, the Chronic Obstructive Pulmonary Disease pipeline constitutes 65+ key companies continuously working towards developing 70+ Chronic Obstructive…
Biliary Tract Cancer Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Biliary Tract Cancers Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in the Biliary Tract Cancers Pipeline landscape.…
X-linked Adrenoleukodystrophy Pipeline Therapeutics Assessment Report 2024 (Upda …
DelveInsight's, "X-Linked Adrenoleukodystrophy Pipeline Insight, 2024," report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in X-Linked Adrenoleukodystrophy (X-ALD) pipeline landscape. It covers…
Polymyositis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Polymyositis Pipeline Insight 2024" report provides comprehensive insights about 7+ companies and 7+ pipeline drugs in Polymyositis pipeline landscape. It covers the pipeline drug…
Alcohol Use Disorder Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Alcohol Use Disorder Pipeline Insight, 2024" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Alcohol Use Disorder pipeline landscape. It…
Obesity Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Obesity Pipeline Insight 2024" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Obesity pipeline landscape. It covers the pipeline drug…
Hairy Cell Leukemia Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Hairy Cell Leukemia Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Hairy Cell Leukemia pipeline landscape. It…
Acute Kidney Injury Market Size in the 7MM was ~USD 6,230 million in 2022, estim …
DelveInsight's "Acute Kidney Injury Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Acute Kidney Injury, historical and forecasted…
Acute Respiratory Distress Syndrome Pipeline Therapeutics Assessment Report 2024 …
DelveInsight's, "Acute Respiratory Distress Syndrome Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline…
Amyotrophic Lateral Sclerosis Pipeline Therapeutics Assessment Report 2024 (Upda …
DelveInsight's, "Amyotrophic Lateral Sclerosis Pipeline Insight 2024" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Amyotrophic Lateral Sclerosis pipeline landscape. It…
Chronic Spontaneous Urticaria Pipeline Therapeutics Assessment Report 2024 (Upda …
DelveInsight's, "Chronic Spontaneous Urticaria Pipeline Insight, 2024," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Chronic Spontaneous Urticaria pipeline landscape. It…
Cluster Headache Syndrome Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Cluster Headache Syndrome Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cluster Headache Syndrome pipeline landscape. It…
ER+ HER2-VE Breast Cancer Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "ER positive, HER2 negative Breast Cancer Pipeline Insight, 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in ER positive, HER2…
Fanconi Anemia Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Fanconi Anemia Pipeline Insight 2024" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Fanconi Anemia pipeline landscape. It covers the…
Diabetic Kidney Disease Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
United States, Nevada, Las Vegas, DelveInsight's 'Diabetic Kidney Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Kidney Disease…
Diabetic Macular Edema Clinical Trials | A Drug Pipeline Analysis Report 2024 | …
DelveInsight's 'Diabetic Macular Edema Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Macular Edema therapies in various stages of…
Diabetic Nephropathy Clinical Trials | A Drug Pipeline Analysis Report 2024 | Ba …
United States, Nevada, Las Vegas, DelveInsight's 'Diabetic Nephropathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Nephropathy therapies in…
Sickle Cell Disease Clinical Trials | A Drug Pipeline Analysis Report 2024 | Bel …
DelveInsight's 'Sickle Cell Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Sickle Cell Disease therapies in various stages of…
Diabetic Neuropathic Pain Clinical Trials | A Drug Pipeline Analysis Report 2024 …
DelveInsight's 'Diabetic Neuropathic Pain Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Neuropathic Pain therapies in various stages of…
Diabetic Peripheral Neuropathy Clinical Trials, Key Companies, Emerging Therapie …
DelveInsight's 'Diabetic Peripheral Neuropathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Peripheral Neuropathy therapies in various stages of…
Short Bowel Syndrome Clinical Trials | A Drug Pipeline Analysis Report 2024 | Ze …
DelveInsight's 'Short Bowel Syndrome Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Short Bowel Syndrome therapies in various stages of…
Diffuse Cutaneous Systemic Sclerosis Clinical Trials | A Drug Pipeline Analysis …
DelveInsight's 'Diffuse Cutaneous Systemic Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diffuse Cutaneous Systemic Sclerosis therapies in various…
Severe Hypertriglyceridemia Clinical Trials | A Drug Pipeline Analysis Report 20 …
DelveInsight's 'Severe Hypertriglyceridemia Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Severe Hypertriglyceridemia therapies in various stages of clinical development,…
Septic Shock Clinical Trials | A Drug Pipeline Analysis Report 2024 | Adrenomed, …
DelveInsight's 'Septic Shock Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Septic Shock therapies in various stages of clinical development,…
Developmental and Epileptic Encephalopathy Clinical Trials | A Drug Pipeline Ana …
United States, Nevada, Las Vegas, DelveInsight's 'Developmental and Epileptic Encephalopathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Developmental and…
Diabetes Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Diabetes Pipeline Insight 2024" report provides comprehensive insights about 200+ companies and 200+ pipeline drugs in Diabetes pipeline landscape. It covers the pipeline drug…
Diabetes Clinical Trials | A Drug Pipeline Analysis Report 2024 | Daewoong, Jans …
DelveInsight's 'Diabetes Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetes therapies in various stages of clinical development, major pharmaceutical…
Diabetic Foot Ulcer Clinical Trial Pipeline Analysis Featuring 34+ Key Companies …
DelveInsight's 'Diabetic Foot Ulcer Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Foot Ulcer therapies in various stages of…
Dravet Syndrome Clinical Trials | A Drug Pipeline Analysis Report 2024 | Compani …
DelveInsight's 'Dravet Syndrome Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Dravet Syndrome therapies in various stages of clinical development;…
Diabetic Retinopathy Clinical Trials | A Drug Pipeline Analysis Report 2024 | Co …
DelveInsight's 'Diabetic Retinopathy Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Diabetic Retinopathy therapies in various stages of clinical development,…
Cutaneous T-Cell Lymphoma Clinical Trials | A Drug Pipeline Analysis Report 2024 …
DelveInsight's 'Cutaneous T-Cell Lymphoma Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cutaneous T-Cell Lymphoma therapies in various stages of…
Fecal Incontinence Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Fecal Incontinence Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Fecal Incontinence pipeline landscape. It covers the…
Cystic Fibrosis Clinical Trials | A Drug Pipeline Analysis Report 2024 | Compani …
DelveInsight's 'Cystic Fibrosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cystic Fibrosis therapies in various stages of clinical development,…
Cystinosis FDA Approvals, Clinical Trials and Pipeline Insights 2024 | AVROBIO, …
DelveInsight's 'Cystinosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cystinosis therapies in various stages of clinical development, major pharmaceutical…
Cytokine Release Syndrome FDA Approvals, Clinical Trials and Pipeline Insights 2 …
DelveInsight's 'Cytokine Release Syndrome Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cytokine Release Syndrome therapies in various stages of…
Cytomegalovirus FDA Approvals, Clinical Trials and Pipeline Insights 2024 | Mode …
DelveInsight's 'Cytomegalovirus Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cytomegalovirus therapies in various stages of clinical development, major pharmaceutical…
Fibrodysplasia Ossificans Progressiva Pipeline Therapeutics Assessement Report 2 …
DelveInsight's, "Fibrodysplasia ossificans progressive Pipeline Insight 2024" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Fibrodysplasia ossificans progressiva pipeline landscape. It…
Cutaneous Lupus Erythematosus FDA Approvals, Clinical Trials and Pipeline Insigh …
United States, Nevada, Las Vegas, DelveInsight's 'Cutaneous Lupus Erythematosus Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cutaneous Lupus Erythematosus…
Deep Vein Thrombosis FDA Approvals, Clinical Trials and Pipeline Insights 2024 | …
United States, Nevada, Las Vegas, DelveInsight's 'Deep Vein Thrombosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Deep Vein Thrombosis…
Degenerative Disc Disease Clinical Trials | A Drug Pipeline Analysis Report 2024 …
DelveInsight's 'Degenerative Disc Disease Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Degenerative Disc Disease therapies in various stages of…
Dengue Clinical Trials | A Drug Pipeline Analysis Report 2024 | Takeda, Merck Sh …
United States, Nevada, Las Vegas, DelveInsight's 'Dengue Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Dengue therapies in various stages…
